Owner and operator of a non-opioid analgesic and neurology specialty pharmaceutical company intended to provide the benefits of safe and effective pain management without the limitations and risks of abuse and misuse that come with opioids. The company's lead product is a novel, alcohol-free formulation of ketorolac in a pre-mixed bag for continuous IV infusion which has the potential to maintain pain relief at an opioid level, enabling physicians to reduce the use of opioids in clinical settings and transform the way pain is treated.